Table 1 Distribution of gender, smoking status, age, BMI and symptom severity during baseline assessment in the six study groups.
Heart rate reactivity groups in BAT non-avoiding patients | BAT active avoiding patients | |||||||
---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | Comparison between 5 non-avoiding groups | Comparison between group 5 and active avoiders | ||
(n = 37) | (n = 37) | (n = 38) | (n = 37) | (n = 37) | (n = 46) | |||
n (%) | ||||||||
Women | 22 (59.5) | 24 (64.9) | 25 (65.8) | 27 (73) | 31 (83.8) | 42 (91.3) | Chi2(4) = 6.14, p = 0.19 | Chi2(1) = 1.09, p = 0.30 |
Smokers | 18 (50) | 13 (35.1) | 14 (36.8) | 20 (54.1) | 12 (32.4) | 14 (30.4) | Chi2(4) = 6.68, p = 0.23 | Chi2(1) = 0.04, p = 0.85 |
Mean (SD) | ||||||||
Age (years) | 32.59 (10.11) | 35.59 (10.29) | 34.92 (11.80) | 35.46 (10.58) | 33.19 (9.47) | 31.76 (10.49) | F(4,181) = 0.64, p = 0.64 | F(1,81) = 0.41, p = 0.52 |
BMI (kg/m2) | 24.99 (5.14) | 24.02 (3.87) | 23.14 (3.21) | 22.93 (3.60) | 23.99 (3.86) | 24.58 (5.69) | F(4,167) = 1.47, p = 0.21 | F(1,74) = 0.26, p = 0.61 |
CGI (1–7) | 5.43 (0.56) | 5.30 (0.74) | 5.26 (0.69) | 5.35 (0.79) | 5.27 (0.69) | 5.22 (0.66) | F(4,181) = 0.38, p = 0.82 | F(1,81) = 0.13, p = 0.72 |
SIGH-A (0–56) | 24.30 (4.84) | 24.41 (5.61) | 24.21 (4.45) | 24.65 (5.12) | 23.81 (5.64) | 25.07 (5.84) | F(4,181) = 0.13, p = 0.97 | F(1,81) = 0.97, p = 0.33 |
Number of PA (0–4) | 2.76 (2.35) | 2.62 (2.61) | 2.61 (2.22) | 2.05 (2.11) | 2.32 (2.27) | 2.87 (2.42) | F(4,181) = 0.55, p = 0.70 | F(1,81) = 1.09, p = 0.29 |
PAS (0–57) | 29.02 (7.69) | 28.75 (11.16) | 26.37 (11.01) | 27.11 (11.03) | 26.23 (8.64) | 28.95 (8.49) | F(4,181) = 0.64, p = 0.64 | F(1,81) = 2.06, p = 0.16 |
MI Alone (1–5) | 2.90 (0.75) | 2.89 (0.76) | 2.83 (0.71) | 2.96 (0.98) | 2.84 (0.78) | 3.09 (0.88) | F(4,166) = 0.16, p = 0.96 | F(1,72) = 1.64, p = 0.21 |
BDI-II (0–63) | 18.08 (7.39) | 15.89 (8.63) | 15.03 (8.18) | 17.24 (9.10) | 17.27 (7.98) | 16.76 (8.93) | F(4,181) = 0.82, p = 0.52 | F(1,81) = 0.07, p = 0.79 |